DEFINISSE / RELIFE MENARINI GROUP

DEFINISSE / RELIFE MENARINI GROUP

RELIFE - MENARINI GROUPRELIFE: Dermatology and Aesthetic Medicine Solutions by Menarini

GAMME RELIFE DEFINISSE FILLERS MENARINI GROUP FRANCE

For natural results, discreet aesthetic results and an expressive face that transmits their emotions. RELIFE TO CHOOSE A GOOD FILLER TO REDEFINE, REDESIGN AND REVEAL THE BEAUTY OF THE MOMENT.
XTR INNOVATIVE XTR ™ TECHNOLOGY. EXCELLENT THREE-DIMENSIONAL CROSS-LINING) TECHNOLOGY DEFINISSE ™ FILLER. DEFINISSE FILLER = A "HIGH QUALITY" SYRINGE SYRINGE TECHNOLOGY GRIP COMFORT VISUAL ORIENTATION.
SAFE PREHENSION.
INNOVATIVE DESIGN. R
ESORBABLE SUPPORT THREADS. RETHINK THE CONTOURS.

  • Relife Definisse touch 23 mg / ml + Lidocaine
  • Relife Definisse restore 23 mg / ml + Lidocaine
  • Relife Definisse core 25 mg / ml + Lidocaine

RELIFE is an ambitious and innovative project, which aims to promote a revolutionary approach in dermatology and aesthetic medicine. A new company, based on the avant-garde scientific tradition and on the high quality standards of the Menarini group, founded in Italy in 1886 and among the world's leading pharmaceutical groups.

INTEGRATED APPROACH TO AESTHETIC MEDICINE.

RELIFE believes in a comprehensive approach to Aesthetic Medicine. RELIFE integrated approach arises from daily practice needs and through a process of conscious innovation to provide doctors with effective and professional technologies and allowing to address aesthetic targets. Only an integrated approach allows to treat aesthetic concerns while keeping their own unique look and improving the patient's self-confidence and positive feelings.  Science and art come together to bring unique look to the world, an integrated approach in Aesthetic Medicine which considers the arising needs and turns into an effective tool in doctors’ hands. Our strategy is made up of 3 different product categories and leverages on 3 therapeutic areas, the 3R: Reshape (facial curves and lines), Restore (face volumes); Resurface (face skin).